
UNIIQ
Description
UNIIQ is a distinctive regional venture fund based in The Hague, Netherlands, specifically designed to foster innovation within the province of South Holland. Established through a unique collaboration between prominent academic institutions—Erasmus MC, TU Delft, and Leiden University—and the regional development agency InnovationQuarter, UNIIQ plays a crucial role in supporting early-stage, deep-tech ventures. Its primary mission is to accelerate the market entry of groundbreaking innovations, particularly those emerging from academic research, by providing essential capital during the critical Proof-of-Concept phase. This strategic focus helps bridge the notorious "valley of death" between scientific discovery and commercial viability.
The fund's investment strategy is centered on providing convertible loans, a flexible financing instrument well-suited for nascent companies that may not yet be ready for traditional equity rounds. UNIIQ targets companies in the Proof-of-Concept stage, where initial funding is vital for validating technologies, building prototypes, and conducting market feasibility studies. This early-stage support is crucial for de-risking innovative projects and making them more attractive for subsequent larger investment rounds. The collaboration with leading universities ensures a strong pipeline of high-potential, knowledge-intensive startups across various sectors, including life sciences, medical technology, clean energy, and advanced manufacturing.
UNIIQ operates with a total fund capital of approximately €22 million, equivalent to about $23.76 million USD. This capital is deployed through individual investments structured as convertible loans, with a typical maximum cheque size of €300,000, or approximately $324,000 USD. While the fund can provide up to this amount, its typical first cheques for promising ventures often range from €150,000, or about $162,000 USD, reflecting its commitment to providing substantial, yet appropriate, early-stage capital. These investments are designed to help companies achieve specific milestones that demonstrate commercial potential and prepare them for follow-on funding from private investors or larger venture capital firms.
Investor Profile
UNIIQ has backed more than 68 startups, with 6 new investments in the last 12 months alone. The firm has led 41 rounds, about 60% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Pre Seed, Series Unknown rounds (top funding stages).
- Majority of deals are located in The Netherlands, Canada, France.
- Strong thematic focus on Biotechnology, Health Care, Manufacturing.
- Led 4 rounds in the past year.
- Typical check size: $162K – $324K.
Stage Focus
- Seed (85%)
- Pre Seed (12%)
- Series Unknown (3%)
Country Focus
- The Netherlands (96%)
- Canada (1%)
- France (1%)
- United States (1%)
Industry Focus
- Biotechnology
- Health Care
- Manufacturing
- Software
- Medical
- Information Technology
- Hardware
- Therapeutics
- Artificial Intelligence (Ai)
- Pharmaceutical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does UNIIQ frequently co-invest with?
Which angels does UNIIQ often collaborate with?
What are some of recent deals done by UNIIQ?
Find More Investors Like UNIIQ
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides









